Posts Tagged ‘compulsory licensing’
Every dose counts (and costs): Access to antiretrovirals and compulsory licensing
In Colombia, HIV is a visible and urgent challenge that affects thousands of people and puts many more at risk. Despite World Health Organization (WHO) recommendations to use Dolutegravir as first-line treatment due to its high effectiveness and minimal side effects, the high cost of the drug prevented its access to a large part of the population.
Read More